Deadline in 6 Days

Kessler Topaz Meltzer & Check, LLP Reminds The Chemours Company Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm (CC)

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) (“Chemours” or the “Company”) on behalf of investors who purchased or acquired Chemours common stock between February 10, 2023 and February 28, 2024, inclusive (the “Class Period”). This action, captioned Taylor Jr. v. The Chemours Company, et al., Case No. 1:24-cv-00361-RGA, was filed in the United States District Court for the District of Delaware.

Important Deadline Reminder: Investors who purchased or otherwise acquired Chemours common stock during the Class Period may, no later than May 20, 2024, move the Court to serve as lead plaintiff for the class.

CLICK HERE TO SUBMIT YOUR CHEMOURS LOSSES. YOU CAN ALSO CLICK ON THE FOLLOWING LINK OR COPY AND PASTE IN YOUR BROWSER: https://www.ktmc.com/new-cases/the-chemours-company?utm_campaign=cc&am ...

CANNOT VIEW THIS VIDEO? PLEASE CLICK HERE. YOU CAN ALSO COPY AND PASTE THIS LINK IN YOUR BROWSER: https://youtu.be/YhqGU3FGmvU

LEAD PLAINTIFF DEADLINE: MAY 20, 2024

CLASS PERIOD: FEBRUARY 10, 2023 THROUGH FEBRUARY 28, 2024

CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:
Jonathan Naji, Esq. [phone] or Email at [e-mail]

DEFENDANTS’ ALLEGED MISCONDUCT

After the market closed on February 9, 2023, Chemours announced its fourth quarter and full year 2022 financial results. Chemours reported Free Cash Flow (defined as cash flows from operations, less purchases of property, plant, and equipment) of $94 million in the fourth quarter of 2022 and $447 million in full year 2022, “demonstrating [Chemours’s] continuing ability to generate strong Free Cash Flow.”

The following day, February 10, 2023 (the first day of the Class Period), Chemours filed its 2022 annual report on Form 10-K (the “2022 Annual Report”) with the SEC and reiterated that it generated Free Cash Flow of $447 million in full year 2022. In connection with the 2022 Annual Report, the Company’s CEO, Mark Newman, and then-CFO, Sameer Ralhan, certified the accuracy of the Company’s financial reports and the adequacy of the Company’s internal control over financial reporting. Thereafter and throughout the Class Period, Chemours reported quarterly and year-to-date Free Cash Flow metrics in each of the Company’s quarterly financial reports and certain Defendants certified the accuracy of the Company’s financial reports and the adequacy of the Company’s internal control over financial reporting.